{"id":"W2109611268","doi":"10.1016/s1470-2045(15)00201-6","title":"Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital","funders":"National Cancer Institute; Sunesis","keywords":"Cytarabine; Medicine; Refractory (planetary science); Placebo; Myeloid leukaemia; Double blind; Internal medicine; Chemotherapy; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001653209,0.00166621,0.003677585,0.0004550391,0.0003935827,0.001080399,0.0009549537,0.00159353,0.004700141],"category_scores_gemma":[0.001483742,0.0006337194,0.00208979,0.0004655897,0.001265979,0.001102369,0.0004305733,0.002818051,0.0009105904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006300203,"about_ca_system_score_gemma":0.0009386914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001140168,"about_ca_topic_score_gemma":0.002453462,"domain_scores_codex":[0.9993393,0.0003866652,0.00003345717,0.0000964603,0.0000352473,0.0001088499],"domain_scores_gemma":[0.9990314,0.0003273627,0.0001946683,0.00007268862,0.00004650475,0.0003273867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9873232,0.002721478,0.00023869,0.0003092675,0.0004402157,0.00001660321,0.00003706171,0.0001864838,0.001707228,0.00004772616,0.0002260839,0.006746019],"study_design_scores_gemma":[0.9319389,0.06599829,0.001080671,0.00001586782,0.000233669,0.00001722569,0.00001952094,0.0001886312,0.0001938872,0.00007660189,0.0002255091,0.00001126396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926516,0.003139668,0.000453916,0.000373096,0.0004147127,0.001431512,0.0005121714,0.0001005947,0.0009226614],"genre_scores_gemma":[0.9911873,0.002325431,0.0009037509,0.0005976124,0.0003631422,0.001408308,0.0006171274,0.0000259563,0.002571528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004700141,"threshold_uncertainty_score":0.01572359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09009627044355988,"score_gpt":0.3851158234666294,"score_spread":0.2950195530230695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}